Upon publication of this paper in Volume 101, the authors noticed an error in the data contained within Table 3, taken from their original manuscript. The incidence of alopecia in CMF group should have been 39.3%, not 9.3%. The correct data are now shown, below.
The online version of the original article can be found at 10.1038/sj.bjc.6605218
About this article
Cite this article
Park, Y., Okamura, K., Mitsuyama, S. et al. Erratum: Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study. Br J Cancer 101, 1031 (2009) doi:10.1038/sj.bjc.6605295